AI Article Synopsis
- Blood clots are complex living tissues that release inflammatory substances, prompting the need for better understanding to improve therapies for blood-related diseases.
- Researchers conducted RNA sequencing and other analyses on cultured blood clots to identify gene expression changes in immune cells, revealing a common immune response pattern.
- The findings suggest that activated immune cells in blood clots play a protective role during inflammation, highlighting the potential of cultured clots as models for studying inflammation and personalizing treatment strategies.
Article Abstract
Background: Blood clots are living tissues that release inflammatory mediators including IL-8/CXCL8 and MCP-1/CCL2. A deeper understanding of blood clots is needed to develop new therapies for prothrombotic disease states and regenerative medicine.
Objectives: To identify a common transcriptional shift in cultured blood clot leukocytes.
Methods: Differential gene expression of whole blood and cultured clots (4 hours at 37 °C) was assessed by RNA sequencing (RNAseq), reverse transcriptase-polymerase chain reaction, proteomics, and histology (23 diverse healthy human donors). Cultured clot serum bioactivity was tested in endothelial barrier functional assays.
Results: All cultured clots developed a polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) signature, including up-regulation of OLR1 (mRNA encoding lectin-like oxidized low-density lipoprotein receptor 1 [Lox-1]), IL-8/CXCL8, CXCL2, CCL2, IL10, IL1A, SPP1, TREM1, and DUSP4/MKP. Lipopolysaccharide enhanced PMN-MDSC gene expression and specifically induced a type II interferon response with IL-6 production. Lox-1 was specifically expressed by cultured clot CD15 neutrophils. Cultured clot neutrophils, but not activated platelets, shed copious amounts of soluble Lox-1 (sLox-1) with a donor-dependent amplitude. sLox-1 shedding was enhanced by phorbol ester and suppressed by heparin and by beta-glycerol phosphate, a phosphatase inhibitor. Cultured clot serum significantly enhanced endothelial cell monolayer barrier function, consistent with a proresolving bioactivity.
Conclusion: This study suggests that PMN-MDSC activation is part of the innate immune response to coagulation which may have a protective role in inflammation. The cultured blood clot is an innovative thrombus model that can be used to study both sterile and nonsterile inflammatory states and could be used as a personalized medicine tool for drug screening.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11584067 | PMC |
| http://dx.doi.org/10.1016/j.jtha.2023.12.014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- The text discusses the importance of forecasting future health issues in the USA for effective planning and public awareness regarding disease and injury burdens.
- It describes the methodology for predicting life expectancy, cause-specific mortality, and disability-adjusted life-years (DALYs) from 2022 to 2050 using the Global Burden of Diseases framework.
- The forecasting includes various scenarios to assess the potential impacts of health risks and improvements across the country, focusing on demographic trends and health-related risk factors.
Novel Rat Model of Embolic Cerebral Ischemia Using a Radiopaque Blood Clot and a Microcatheter Under Fluoroscopy.
Transl Stroke Res
November 2024
Department of Neurology, The Jikei University School of Medicine, 3-25-8 Nishishimbashi, Minato-Ku, Tokyo, 105-8461, Japan.
Article Synopsis
- Researchers developed a new rat model of thromboembolic stroke to achieve consistent infarct sizes and locations within the middle cerebral artery (MCA) without needing arterial ligation.
- The model involved using a microcatheter to place a zirconium dioxide blood clot in the artery, and monitoring was done through fluoroscopy over 24 hours.
- The results showed that the blood clot position remained stable in most rats, with a median infarct volume of 242 mm, highlighting the model's potential for testing new stroke treatments.
Intracerebral Hemorrhage.
Cerebrovasc Dis Extra
December 2024
Stroke Center and Department of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Background: Compared to ischemic stroke, intracerebral hemorrhage (ICH) has higher mortality and more severe disability. Asian such as Chinese and Japanese and Mexican Americans, Latin Americans, African Americans, Native Americans has higher incidences than do white Americans. So, ICH is an important cerebrovascular disease in Asia.
View Article and Find Full Text PDFA Case Report of Methicillin-Resistant Staphylococcus aureus-Related Pericardial Empyema: A Deadly Cardiac Risk.
Cureus
October 2024
Internal Medicine, Nuvance Health, Poughkeepsie, USA.
Article Synopsis
- Pericardial empyema is a rare but serious condition, typically discovered after death, often caused by Staphylococcus aureus, especially MRSA.
- A 73-year-old man with diabetes and hypothyroidism showed symptoms like fever and skin infection, leading to the discovery of MRSA and treatment with Vancomycin.
- Despite emergency procedures, the patient developed severe complications, resulting in his death, highlighting the importance of quick diagnosis and treatment for better outcomes.
Bovine pulp extracellular matrix hydrogel for regenerative endodontic applications: in vitro characterization and in vivo analysis in a necrotic tooth model.
Head Face Med
October 2024
Conservative Dentistry Department, Faculty of Dentistry, Alexandria University, Alexandria, Egypt.
Background: Regenerative endodontic procedures (REPs) offer the promise of restoring vitality and function to a previously necrotic and infected tooth. However, the nature of regenerated tissues following REPs remains unpredictable and uncontrollable. Decellularized extracellular matrix scaffolds have gained recent attention as scaffolds for regenerative endodontics.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!